Placement & Rights Issue to Raise Additional Working Capital
Filed with ASX ·
6ix hasn’t read this filing yet.
Amplia Therapeutics Ltd. on 6ix
Earlier from Amplia Therapeutics
- Preliminary Final Report - YE 31 March 2016
- Appendix 4C - Statement of Cashflows March 2016 Qtr
- Clinical Trial Fully Enrolled and Strong Interest
- Update on Innates Phase 2B trial and recent activities
- Appendix 4C - Dec 2013 Quarterly Cash Flow Statement
Later from Amplia Therapeutics
- Rights Issue Booklet
- Final Stage of Capital Raising Programme Completed
- Appendix 4C - quarterly - June 16 Qtr
- Clinical Trials Update - 2016 Bioshares Biotech Summit
- Appendix 4C - Quarterly Cashflows Report - Sept 2016 Qtr
Follow Amplia Therapeutics into a list and get an email when it puts out news.
Follow Amplia Therapeutics